<DOC>
	<DOCNO>NCT01512966</DOCNO>
	<brief_summary>This study ass safety tolerability intravitreally ( IVT ) administer VEGF Trap-Eye Japanese subject diabetic macular edema ( DME ) period one year .</brief_summary>
	<brief_title>Japanese Safety Study VEGF Trap-Eye DME ( Diabetic Macular Edema )</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<criteria>Adults â‰¥ 18 year type 1 2 diabetes mellitus Subjects DME ( diabetic macular edema ) secondary diabetes mellitus involve center macula study eye BCVA ( bestcorrected visual acuity ) ETDRS ( Early Treatment Diabetic Retinopathy Study ) letter score 73 24 ( 20/40 20/320 ) study eye Active proliferative diabetic retinopathy ( PDR ) study eye Uncontrolled diabetes mellitus , define HbA1c &gt; 12 % Only 1 functional eye even eye otherwise eligible study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Diabetic Macular Edema</keyword>
	<keyword>DME</keyword>
	<keyword>VEGF Trap-Eye</keyword>
	<keyword>best-corrected visual acuity ( BCVA )</keyword>
</DOC>